Reducing immune rejection related therapies using "stealth" technologies

This Clarity Insight was a logical extension to the biobanking and off-the-shelf therapy insights. Concerns of Graft vs Host Disease remain a concern to this day. Nevertheless, many technologies and gene modifications are possible to today thanks to advancement in the field. This insight shares some perspective on the matter.